Macronutrients, aluminium from drinking water and foods, and other metals in cognitive decline and dementia

Journal of Alzheimer's Disease

Volumn 10, Issue 2-3, 2006, Pages 303-330

  Solfrizzi, Vincenzo ^a   Colacicco, Anna Maria ^a   D'Introno, Alessia ^a   Capurso, Cristiano ^b   Parigi, Angelo Del ^c   Capurso, Sabrina A ^a   Torres, Francesco ^a   Capurso, Antonio ^a   Panza, Francesco ^a  

^a UNIVERSITY OF BARI   (Italy)

^b UNIVERSITY OF FOGGIA   (Italy)

^c JOHN B PIERCE LABORATORY   (United States)

Author keywords

Aluminium; Alzheimer's disease; Carbohydrates; Copper; Dementia; Diet; Iron; Proteins; Vascular dementia

Indexed keywords

ALCOHOL; ALPHA TOCOPHEROL; ALUMINUM; ANTIOXIDANT; CAROTENOID; CERULOPLASMIN; DRINKING WATER; FLAVONOID; GINKGO BILOBA EXTRACT; MELATONIN; METAL; TRYPTOPHAN; UNSATURATED FATTY ACID; ZINC;

ALCOHOLIC BEVERAGE; ALZHEIMER DISEASE; CARBOHYDRATE INTAKE; CLINICAL TRIAL; COGNITION; COGNITIVE DEFECT; COPPER BLOOD LEVEL; FOOD COMPOSITION; FOOD INTAKE; GLUCOSE INTAKE; GLUCOSE UTILIZATION; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; IRON METABOLISM; MACRONUTRIENT; METABOLIC DISORDER; MINI MENTAL STATE EXAMINATION; MULTIINFARCT DEMENTIA; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NUTRIENT CONCENTRATION; NUTRITIONAL DEFICIENCY; NUTRITIONAL DISORDER; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN INTAKE; REVIEW; VEGETABLE; WATER CONTAMINATION; WINE;

EID: 33751081020     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/JAD-2006-102-314     Document Type: Review

References (299)

1. J.B. Allen, A.M. Gross, M.S. Aloia and C. Billingsley, The effects of glucose on nonmemory cognitive functioning in the elderly, Neuropsychologia 34 (1996), 459-465.
2. American College of Medical Genetics/American Society of Human Genetics Working Group on ApoE and Alzheimer disease, Statement on use of apolipoprotein E testing for Alzheimer disease, J.A.M.A. 274 (1995), 1627-1629.
3. American Psychiatric Association Committee on Nomenclature and Statistics. Diagnostic and Statistical Manual of Mental Disorders. American Psychiatric Association, Washington, DC, 1994.
4. S.A. Amiel, R.C. Pottinger, H.R. Archibald, G. Chusney, D.T. Cunnah, P.F. Prior and E.A. Gale, Effect of antecedent glucose control on cerebral function during hypoglycemia, Diabetes Care 14 (1991), 109-118.
5. I.M. Anderson, M. Parry-Billings, E.A. Newsholme, C.G. Fairburn and P.J. Cowen, Dieting reduces plasma tryptophan and alters brain 5-HT function in women, Psychol. Med. 20 (1990), 785-791.
6. T. Anttila, E.L. Helkala, M. Viitanen, I. Kareholt, L. Fratiglioni, B. Winblad, H. Soininen, J. Tuomilehto, A. Nissinen and M. Kivipelto, Alcohol drinking in middle age and subsequent risk of mild cognitive impairment and dementia in old age: a prospective population based study, B.M.J. 329 (2004), 539.
7. D.V. Ashley, R. Liardon and P.D. Leathwood, Breakfast meal composition influences plasmatryptophan to large neutral amino acid ratios of healthy lean young men, J. Neural. Transm. 63 (1985), 271-283
8. H. Atamna, P.B. Walter and B.N. Ames, The role of heme and iron-sulfur clusters in mitochondrial biogenesis, maintenance, and decay with age. Arch. Biochem. Biophys. 397 (2002), 345-353.
9. H. Atamna and W.H. Frey, 2nd, A role for heme in Alzheimer's disease: heme binds amyloid beta and has altered metabolism, Proc. Natl. Acad. Sci. USA. 101 (2004), 11153-11158.
10. C.S. Atwood, X. Huang, R.D. Moir, R.E. Tanzi and A.I. Bush, Metal Ions Biol. Syst. 36 (1999), 309-364.
11. C.S. Atwood, G. Perry, H. Zeng, Y. Kato, W.D. Jones, K.Q. Ling, X. Huang, R.D. Moir, D. Wang, L.M. Sayre, M.A. Smith, S.G. Chen and A.I. Bush, Copper mediates dityrosine cross-linking of Alzheimer's amyloid-beta, Biochemistry 43 (2004), 560-568.
12. E.J. Austin and I.J. Deary, Effects of repeated hypoglycemia on cognitive function: a psychometrically validated reanalysis of the Diabetes Control and Complications Trial data, Diabetes Care 22 (1999), 1273-1277.
13. P. Barberger-Gateau, L. Letenneur, V. Deschamps, K. Peres, J.F. Dartigues and S. Renaud, Fish, meat, and risk of dementia: cohort study, B.M.J. 325 (2002), 932-933.
14. G. Bartzokis, D. Sultzer, J. Cummings, L.E. Holt, D.B. Hance, V.W. Henderson and J. Mintz, In vivo evaluation of brain iron in Alzheimer disease using magnetic resonance imaging, Arch. Gen. Psychiatry. 57 (2000), 47-53.
15. G. Bartzokis, T.A. Tishler, I.S. Shin, P.H. Lu and J.L. Cummings, Brain ferritin iron as a risk factor for age at onset in neurodegenerative diseases, Ann. N. Y. Acad. Sci. 101 (2004), 224-236.
16. H. Basum, L.G. Forssell, L.G. Wetterberg and B. Winblad, Metals and trace elements in plasma and cerebrospinal fluid in normal aging and Alzheimer's disease, J. Neural Transm. Parkinson's Dis. Dementia 3 (1991), 231-258.
17. L. Baum and A. Ng, Curcumin interaction with copper and iron suggests one possible mechanism of action in Alzheimer's disease animal models, J. Alzheimers Dis. 6 (2004), 367-377.
18. T.A. Bayer, S. Schäfer, A. Simons, A. Kemmling, T. Kamer, R. Tepest, A. Eckert, K. Schüssel, O. Eikenberg, C. Sturchler-Pierrat, D. Abramowski, M. Staufenbiel and G. Multhaup, Dietary Cu stabilizes brain superoxide dismutase 1 activity and reduces amyloid Abeta production in APP23 transgenic mice, Proc. Natl. Acad. Sci. USA. 100 (2003), 14187-14192.
19. A. Becaria, A. Campbell and S.C. Bondy, Aluminum as a toxicant, Toxicol. Ind. Health 18 (2002), 309-320.
20. S.A. Bellingham, D.K. Lahiri, B. Maloney, S. La Fontaine, G. Multhaup and J. Camakaris, Copper depletion downregulates expression of the Alzheimer's disease amyloid-beta precursor protein gene, J. Biol. Chem. 279 (2004), 20378-20386.
21. F. Bellisle, J.E. Blundell, L. Dye, M. Fantino, E. Fern, R.J. Fletcher, J. Lambert, M. Roberfroid, S. Specter, J. Westenhofer and M.S. Westerterp-Plantenga, Functional food science and behaviour and psychological functions, Br. J. Nutr. 80 (1998), S173-S193.
22. D.A. Bennett, J.A. Schneider, R.S. Wilson, J.L. Bienias and S.E. Arnold, Neurofibrillary tangles mediate the association of amyloid load with clinical Alzheimer disease and level of cognitive function, Arch. Neurol. 61 (2004), 378-384.
23. D. Benton, D.S. Owens and P.Y. Parker, Blood glucose influences memory and attention in young adults, Neuropsychologia 32 (1994), 595-607.
24. J.D. Birchall and J.S. Chappel, Aluminium, chemical physiology and Alzheimer's disease, Lancet 2 (1988), 1008-1010.
25. T. Borchardt, J. Camakaris, R. Cappai, C.L. Masters, K. Beyreuther and G. Multhaup, Copper inhibits beta-amyloid production and stimulates the non-amyloidogenic pathway of amyloid-precursor-protein secretion, Biochem. J. 344 (1999), 461-467.
26. S. Brenner, Elevation of serum copper levels in Alzheimer's disease, Neurology 60 (2003), 1559.
27. D. Bryce-Smith and N.I. Ward, Aluminium and the blood-brain barrier, J. Alt. & Compl. Med. 1 (1989), 9-10.
28. G.A. Broe, A.S. Henderson, H. Creasey, E. McCusker, A.E. Korten, A.F. Jorm, W. Longley and J.C. Anthony, A case-control study of Alzheimer's disease in Australia, Neurology 40 (1990), 1698-1707.
29. F.M. Burnet, A possible role of zinc in the pathology of dementia, Lancet 1 (1981), 186-188.
30. A.L. Bush, Metals and neuroscience, Curr. Opin. Biol. Chem. 4 (2000), 184-191
31. D.A. Butterfield, J. Drake, C. Pocernich and A. Castegna, Evidence of oxidative damage in Alzheimer's disease brain: central role for amyloid beta-peptide, Trends Mol. Med. 7 (2001), 548-554.
32. D.A. Butterfield, A. Castegna, C.M. Lauderback and J. Drake, Evidence that amyloid beta-peptide-induced lipid peroxidation and its sequelae in Alzheimer's disease brain contribute to neuronal death, Neurobiol. Aging 23 (2002), 655-664.]
33. D.A. Butterfield and C.M. Lauderback, Lipid peroxidation and protein oxidation in Alzheimer's disease brain: potential causes and consequences involving amyloid beta-peptide-associated free radical oxidative stress, Free Radic. Biol. Med. 32 (2002), 1050-1060.
34. Canadian Study of Health and Aging, The Canadian Study of Health and Aging: Risk factors for Alzheimer's disease in Canada, Neurology 44 (1994), 2073-2080.
35. A. Cervilla, M. Prince and A. Mann, Smoking, drinking, and incident cognitive impairment: a cohort community based study included in the Gospel Oak project, J. Neurol. Neurosurg. Psychiatry 68 (2000), 622-626.
36. J.A. Cervilla, M. Prince, S. Joels, S. Lovestone and A. Mann, Long-term predictors of cognitive outcome in a cohort of older people with hypertension, Br. J. Psychiatry 177 (2000), 66-71.
37. R.A. Cherny, C.S. Atwood, M.E. Xilinas, D.N. Gray, W.D. Jones, C.A. McLean, K.J. Barnham, I. Volitakis, F.W. Fraser, Y. Kim, X. Huang, L.E. Goldstein, R.D. Moir, J.T. Lim, K. Beyreuther, H. Zheng, R.E. Tanzi, C.L. Masters and A.I. Bush, Treatment with a copper-zinc chelator markedly and rapidly inhibits beta-amyloid accumulation in Alzheimer's disease transgenic mice, Neuron 30 (2001), 665-676.
38. D. Commenges, V. Scotet, S. Renaud, H. Jacqmin-Gadda, P. Barberger-Gateau and J.F. Dartigues, Intake of flavonoids and risk of dementia, Eur. J. Epidemiol. 16 (2000), 357-363.
39. C.R. Cornett, W.R. Markesbery and W.D. Ehmann, Imbalances of trace elements related to oxidative damage in Alzheimer's disease brain, Neurotoxicology 19 (1998), 339-345.
40. S. Craft, C. Murphy and J. Wemstrom, Glucose effects on complex memory and nonmemory tasks: the influence of age, sex, and glucoregulatory response, Psychobiology 22 (1994), 95-105.
41. S. Craft, J. Newcomer, S. Kanne, S. Dagogo-Jack, P. Cryer, Y. Sheline, J. Luby, A. Dagogo-Jack and A. Alderson, Memory improvement following induced hyperinsulinemia in Alzheimer's disease, Neurobiol. Aging 17 (1996), 123-130.
42. S. Craft, S. Asthana, J.W. Newcomer, C.W. Wilkinson, I.T. Matos, L.D. Baker, M. Cherrier, C. Lofgreen, S. Latendresse, A. Petrova, S. Plymate, M. Raskind, K. Grimwood and R.C. Veith, Enhancement of memory in Alzheimer disease with insulin and somatostatin, but not glucose, Arch. Gen. Psychiatry 56 (1999), 1135-1140.
43. D.R. Crapper McLachlan, A.J. Dalton, T.P.A. Kruck, M.Y. Bell, W.L. Smith, W. Kalow and D.F. Andrews, Intramuscular desferrioxamine in patients with Alzheimer's disease, Lancet 337 (1991), 1304-1308.
44. M.P. Cuajungco, L.E. Goldstein, A. Nunomura, M.A. Smith, J.T. Lim, C.S. Atwood, X. Huang, Y.W. Farrag, G. Perry and A.I. Bush, Evidence that the beta-amyloid plaques of Alzheimer's disease represent the redox-silencing and entombment of abeta by zinc, J. Biol. Chem. 275 (2000), 19439-19442.
45. M.P. Cuajungco, C.J. Frederickson and A.I. Bush, Amyloid-beta metal interaction and metal chelation, Subcell. Biochem. 38 (2005), 235-254.
46. G. Danscher, K.B. Jensen, C.J. Frederickson, K. Kemp, A. Andreasen, S. Juhl, M. Stoltenberg and R. Ravid, Increased amount of zinc in the hippocampus and amygdala of Alzheimer's diseased brains: a proton-induced X-ray emission spectroscopic analysis of cryostat sections from autopsy material, J. Neurosci. Methods 76 (1997), 53-59.
47. I.J. Deary, J.R. Crawford, D.A. Hepburn, S.J. Langan, L.M. Blackmore and B.M. Frier, Severe hypoglycemia and intelligence in adult patients with insulin-treated diabetes, Diabetes 42 (1993), 341-344.
48. A. Dedeoglu, K. Cormier, S. Payton, K.A. Tseitlin, J.N. Kremsky, L. Lai, X. Li, R.D. Moir, R.E. Tanzi, A.I. Bush, N.W. Kowall, J.T. Rogers and X. Huang, Preliminary studies of a novel bifunctional metal chelator targeting Alzheimer's amyloidogenesis, Exp. Gerontol. 39 (2004), 1641-1649.
49. A. Del Parigi, F. Panza, C. Capurso and V. Solfrizzi, Malnutrition, cognitive decline, and dementia, Brain Res. Bull. (2005), in press.
50. T. den Heijer, S.E. Vermeer, E.J. van Dijk, N.D. Prins, P.J. Koudstaal, C.M. van Duijn, A. Hofman and M.M. Breteler, Alcohol intake in relation to brain magnetic resonance imaging findings in older persons without dementia, Am. J. Clin. Nutr. 80 (2004), 992-997.
51. A. de Mendonca, A.M. Sebastiao and J.A. Ribeiro, Adenosine: does it have a neuroprotective role after all?, Brain. Res. Rev. 33 (2000), 258-274.
52. A. D'Introno, F. Panza, A.M. Colacicco, A. Capurso and V. Solfrizzi, Mild Cognitive Impairment and related entities: role of vascular risk factors, in: Diet and Cognitive Decline, F. Panza, V. Solfrizzi and A. Capurso, eds, NY, USA: Nova Science Publishers, Inc, 2004, pp. 1-33.
53. L. Dye, A. Lluch and J.E. Blundell, Macronutrients and mental performance, Nutrition 16 (2000), 1021-1034.
54. R. Doll, Review: Alzheimer's disease and environmental aluminium, Age Ageing 22 (1993), 138-153.
55. R.S. Doody, J.C. Stevens, C. Beck, R.M. Dubinsky, J.A. Kaye, L. Gwyther, R.C. Mohs, L.J. Thal, P.J. Whitehouse, S.T. DeKosky and J.L. Cummings, Practice parameter: management of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology, Neurology 56 (2001), 1154-1166.
56. C. Dufouil, P. Ducimetiere and A. Alperovitch, Sex differences in the association between alcohol consumption and cognitive performance, EVA Study Group. Epidemiology of Vascular Aging, Am. J. Epidemiol. 146 (1997), 405-412.
57. C. Dufouil, C. Tzourio, C. Brayne, C. Berr, P. Amouyel and A. Alperovitch, Influence of apolipoprotein E genotype on the risk of cognitive deterioration in moderate drinkers and smokers, Epidemiology 11 (2000), 280-284.
58. M.J. Eckardt, S.E. File, G.L. Gessa, K.A. Grant, C. Guerri, P.L. Hoffman, H. Kalant, G.F. Koob, T.K. Li and B. Tabakoff, Effects of moderate alcohol consumption on the central nervous system, Alcohol Clin. Exp. Res. 22 (1998), 998-1040.
59. P.K. Elias, M.F. Elias, R.B. D'Agostino, L.A. Cupples, P.W. Wilson, H. Silbershatz and P.A. Wolf, NIDDM and blood pressure as risk factors for poor cognitive performance. The Framingham Study, Diabetes Care 20 (1997), 1388-1395.
60. P.K. Elias, M.F. Elias, R.B. D'Agostino, H. Silbershatz and P.A. Wolf, Alcohol consumption and cognitive performance in the Framingham Heart Study, Am. J. Epidemiol. 150 (1999), 580-589.
61. S.L. Edelstein, D. Kritz-Silverstein and E. Barrett-Connor, Prospective association of smoking and alcohol use with cognitive function in an elderly cohort, J. Women's Health 7 (1998), 1271-1281.
62. T. Erkinjuntti, D. Inzitari, L. Pantoni, A. Wallin, P. Scheltens, K. Rockwood and D.W. Desmond, Limitations of clinical criteria for the diagnosis of vascular dementia in clinical trials. Is a focus on subcortical vascular dementia a solution? Ann. N. Y. Acad. Sci. 903 (2000), 262-272.
63. C. Exley, The aluminium-amyloid cascade hypothesis and Alzheimer's disease, Subcell. Biochem. 38 (2005), 225-234.
64. F.M. Ewing, I.J. Deary, R.J. McCrimmon, M.W. Strachan and B.M. Frier, Effect of acute hypoglycemia on visual information processing in adults with type 1 diabetes mellitus, Physiol. Behav. 64 (1998), 653-660.
65. F. Fadda and Z.L. Rossetti, Chronic ethanol consumption: from neuroadaptation to neurodegeneration, Prog. Neurobiol. 56 (1998), 385-431.
66. P. Fattoretti, C. Bertoni-Freddari, M. Balietti, B. Giorgetti, M. Solazzi and P. Zatta, Chronic aluminum administration to old rats results in increased levels of brain metal ions and enlarged hippocampal mossy fibers, Ann. N. Y. Acad. Sci. 1019 (2004), 44-47.
67. J.F. Flood, G.E. Smith and J.E. Morley, Modulation of memory processing by cholecystokinin: dependence on the vagus nerve, Science 236 (1987), 832-834.
68. M.T. Fillmore, J.L. Carscadden and M. Vogel-Sprott, Alcohol, cognitive impairment and expectancies, J. Stud. Alcohol. 59 (1998), 174-179.
69. A.E. Finefrock, A.I. Bush and P.M. Doraiswamy, Current status of metals as therapeutic targets in Alzheimer's disease, J. Am. Geriatr. Soc. 51 (2003), 1143-1148.
70. F. Finnigan, R. Hammersley and K. Millar, Effects of meal composition on blood alcohol level, psychomotor performance and subjective state after ingestion of alcohol, Appetite 31 (1998), 361-375.
71. D. Fekkes, T.J. van der Cammen, C.P. van Loon, C. Verschoor, F. van Harskamp, I. de Koning, W.J. Schudel and L. Pepplinkhuizen, Abnormal amino acid metabolism in patients with early stage Alzheimer dementia, J. Neural. Transm. 105 (1998), 287-294.
72. J.D. Fernstrom and R.J. Wurtman, Brain serotonin content: physiological dependence on plasma tryptophan levels, Science 173 (1971), 149-152.
73. J.D. Fernstrom and R.J. Wurtman, Brain serotonin content: physiological regulation by plasma neutral amino acids, Science 178 (1972), 414-416.
74. T.P. Flaten, An Investigation of the Chemical Composition of Norwegian Drinking Water and its Possible Relationships with the Epidemiology of Some Diseases, Department of Chemistry, Norwegian University of Science and Technology, Trondheim, Norway, 1986.
75. T.P. Flaten and M. Ødegård, Tea, aluminium and Alzheimer's disease, Food Chem. Toxicol. 26 (1988), 959-960.
76. T.P. Flaten, Geographical associations between aluminium in drinking water and death rates with dementia (including Alzheimer's disease), Parkinson's disease and amyotrophic lateral sclerosis in Norway, Environ. Geochem. Health 12 (1990), 152-167.
77. T.P. Flaten, Aluminium as a risk factor in Alzheimer's disease, with emphasis on drinking water, Brain Res. Bull. 55 (2001), 187-196.
78. W.F. Forbes, L.M. Hayward and N. Agwani, Dementia, aluminium, and fluoride, Lancet 338 (1991), 1592-1593.
79. W.F. Forbes, L.M. Hayward and N. Agwani, Geochemical risk factors for mental functioning, based on the Ontario Longitudinal Study of Aging (LSA) I. Results from a preliminary investigation, Can. J. Aging 11 (1992), 269-280.
80. W.F. Forbes and N. Agwani, Geochemical risk factors for mental functioning, based on the Ontario Longitudinal Study of Aging (LSA) III. The effects of different aluminum-containing compounds, Can. J. Aging 13 (1994), 488-498.
81. D.P. Forster, A.J. Newens, D.W.K. Kay and J.A. Edwardson, Risk factors in clinically diagnosed presenile dementia of the Alzheimer type: A case-control study in northern England, J. Epidemiol. Community Health 49 (1995), 253-258.
82. J.K. Foster, P.G. Lidder and S.I. Sunram, Glucose and memory: fractionation of enhancement effects?, Psychopharmacology 137 (1998), 259-270.
83. M.F. Frecker, Dementia in Newfoundland: Identification of a geographical isolate?, J. Epidemiol. Community Health 45 (1991), 307-311.
84. B.B. Fredholm, K. Battig, J. Holmen, A. Nehlig and E.E. Zvartau, Actions of caffeine in the brain with special reference to factors that contribute to its widespread use, Pharmacol. Rev. 51 (1999), 83-133.
85. L. Frolich, D. Blum-Degen, H.G. Bernstein, S. Engelsberger, J. Humrich, S. Laufer, D. Muschner, A. Thalheimer, A. Turk, S. Hoyer, R. Zochling, K.W. Boissl, K. Jellinger and P. Riederer, Brain insulin and insulin receptors in aging and sporadic Alzheimer's disease, J. Neural. Transm. 105 (1998), 423-438.
86. K.S. Fuson, L.N. Boggs and P.C. May, Zinc promotes Ab aggregation but attenuates Ab neurotoxicity. Neurobiol. Aging 17(Suppl) (1996), 431.
87. Y.K. Fung, A.G. Meade, E.P. Rack, A.J. Blotcky, J.P. Claassen, M.W. Beatty and T. Durham, Determination of blood mercury concentrations in Alzheimer's patients, J. Toxicol. Clin. Toxicol. 33 (1995), 243-247.
88. Y.K. Fung, A.G. Meade, E.P. Rack and A.J. Blotcky, Brain mercury in neurodegenerative disorders, J. Toxicol. Clin. Toxicol. 35 (1997), 49-54.
89. D.J. Galanis, C. Joseph, K.H. Masaki, H. Petrovich, G.W. Ross and L. White, A longitudinal study of drinking and cognitive performance in elderly Japanese American men: the Honolulu-Asia aging study, Am. J. Public Health 90 (2000), 1254-1259.
90. C. Galbusera, M. Facheris, F. Magni, G. Galimberti, G. Sala, L. Tremolada, V. Isella, F.R. Guerini, I. Appollonio, M. Galli-Kienle and C. Ferrarese, Increased susceptibility to plasma lipid peroxidation in Alzheimer disease patients, Curr. Alzheimer Res. 1 (2004), 103-109.
91. E. Gauthier, I. Fortier, F. Courchesne, P. Pepin, J. Mortimer and D. Gauvreau, Aluminum forms in drinkingwater and risk of Alzheimer's disease, Environ. Res. 84 (2000), 234-246.
92. P. Giannakopoulos, P.R. Hof, J.P. Michel, J. Guimon and C. Bouras, Cerebral cortex pathology in aging and Alzheimer's disease: a quantitative survey of large hospital-based geriatric and psychiatric cohorts, Brain Res. Rev. 25 (1997), 217-245.
93. R.S. Gibson, Content and bioavailability of trace elements in vegetarian diets, Am. J. Clin. Nutr. 59(5 Suppl) (1994), 1223S-1232S.
94. R.S. Gibson, A.L. Heath, M.L. Limbaga, N. Prosser and C.M. Skeaff, Are changes in food consumption patterns associated with lower biochemical zinc status among women from Dunedin, New Zealand? Br. J. Nutr. 86 (2001), 71-80.
95. S. Gillette-Guyonnet, S. Andrieu, F. Nourhashemi, V. de La Gueronniere, H. Grandjean and B. Vellas, Cognitive impairment and composition of drinking water in women: findings of the EPIDOS Study, Am. J. Clin. Nutr. 81 (2005), 897-902.
96. M.W. Gillman, L.A. Cupples, D. Gagnon, B.M. Posner, R.C. Ellison, W.P. Castelli and P.A. Wolf, Protective effect of fruits and vegetables on development of stroke in men, J.A.M.A. 273 (1995), 1113-1117.
97. M.E. Godfrey, D.P. Wojcik and C.A. Krone, Apolipoprotein E genotyping as a potential biomarker for mercury neurotoxicity, J. Alzheimers Dis. 5 (2003), 189-195.
98. W.P. Goldman, J.L. Price, M. Storandt, E.A. Grant, D.W. McKeel, Jr., E.H. Rubin and J.C. Morris, Absence of cognitive impairment or decline in preclinical Alzheimer's disease, Neurology 56 (2001), 361-367.
99. P.S. Goldman-Rakic, Working memory and the mind, Sci. Am. 267 (1992), 110-117.
100. W.B. Grant, Dietary links to Alzheimer's disease, Alz. Dis. Rev. 2 (1997), 42-55.
101. W.B. Grant, Dietary links to Alzheimer's disease: 1999 Update, J. Alzheimer Dis. 1 (1999), 197-201.
102. W.B. Grant, Fish consumption, cancer, and Alzheimer's disease, Am. J. Clin. Nutr. 71 (2000), 599-600.
103. W.B. Grant, A. Campbell, R.F. Itzhaki and J. Savory, The significance of environmental factors in the etiology of Alzheimer's disease, J. Alzheimers Dis. 4 (2002), 179-189.
104. C. Gonzalez, T. Martin, J. Cacho, M.T. Brenas, T. Arroyo, B. Garcia-Berrocal, J.A. Navajo and J.M. Gonzalez-Buitrago, Serum zinc, copper, insulin, and lipids in Alzheimer's disease epsilon 4 apolipoprotein E allele carriers, Eur. J. Clin. Invest. 29 (1999), 637-642.
105. M. Gonzalez-Gross, A. Marcos and K. Pietrzik, Nutrition and cognitive impairment in the elderly, Br. J. Nutr. 86 (1997), 313-321.
106. A. Goate, M.C. Chartier-Harlin, M. Mullan, J. Brown, F. Crawford, L. Fidani, L. Giuffra, A. Haynes, N. Irving, L. James, R. Mant, P. Newton, K. Rooke, P. Roques, C. Talbot, M. Pericak-Vance, A. Roses, R. Williamson, M. Rossor, M. Owen and J. Hardy, Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease, Nature 349 (1991), 704-706.
107. C.E. Greenwood and G. Winocur, Cognitive impairment in rats fed high-fat diets: a specific effect of saturated fatty-acid intake, Behav. Neurosci. 110 (1996), 451-459.
108. C.E. Greenwood, R.J. Kaplan, S. Hebblethwaite and D.J. Jenkins, Carbohydrate-Induced Memory Impairment in Adults With Type 2 Diabetes, Diabetes Care 26 (2003), 1961-1966.
109. J.L. Greger, Dietary and other sources of aluminium intake, in: Aluminium in biology and medicine (Ciba Foundation Symposium No. 169), Chichester: John Wiley, 1992, 26-49.
110. V.B. Gupta, S. Anitha, M.L. Hegde, L. Zecca, R.M. Garruto, R. Ravid, S.K. Shankar, R. Stein, P. Shanmugavelu and K.S. Jagannatha Rao, Aluminium in Alzheimer's disease: are we still at a crossroad? Cell Mol. Life Sci. 62 (2005), 143-158.
111. B. Halliwell and J.M. Gutteridge Lipid peroxidation in brain homogenates: the role of iron and hydroxyl radicals. J Neurochem. 69 (1997), 1330-1331.
112. J.A. Hardy and G.A. Higgins, Alzheimer's disease: The amyloid cascade hypothesis, Science 256 (1992), 184-185.
113. T. Hanninen, M. Hallikainen, K. Koivisto, E.L. Helkala, K.J. Reinikainen, H. Soininen, L. Mykkanen, M. Laakso, K. Pyorala and P.J. Sr Riekkinen, A follow-up study of age-associated memory impairment: neuropsychological predictors of dementia, J. Am. Geriatr. Soc. 43 (1995), 1007-1015.
114. I. Hindmarch, J.S. Kerr and N. Sherwood, The effects of alcohol and other drugs on psychomotor performance and cognitive function, Alcohol Alcohol 26 (1991), 71-79.
115. C. Helmer, E. Peuchant, L. Letenneur, I. Bourdel-Marchasson, S. Larrieu, J.F. Dartigues, L. Dubourg, M.J. Thomas and P. Barberger-Gateau, Association between antioxidant nutritional indicators and the incidence of dementia: results from the PAQUID prospective cohort study, Eur. J. Clin. Nutr. 57 (2003), 1555-1561.
116. H.C. Hendrie, B.O. Osuntokun, K.S. Hall, A.O. Ogunniyi, S.L. Hui, F.W. Unverzagt, O. Gureje, C.A. Rodenberg, O. Baiyewu and B.S. Musick, Prevalence of Alzheimer's disease and dementia in two communities: Nigerian Africans and African Americans, Am. J. Psychiatry 152 (1995), 1485-1492.
117. H. Henon, I. Durieu, D. Guerouaou, F. Lebert, F. Pasquier and D. Leys, Poststroke dementia: incidence and relationship to prestroke cognitive decline, Neurology 57 (2001), 1216-1222.
118. L.E. Herbert, P.A. Scherr, L.A. Beckett, M.S. Albert, B. Rosner, J.O. Taylor and D.A. Evans, Relation of smoking and low-to-moderate alcohol consumption to change in cognitive function: a longitudinal study in a defined community of older persons, Am. J. Epidemiol. 137 (1993), 881-891.
119. C. Hock, G. Drasch, S. Golombowski, F. Muller-Spahn, B. Willershausen-Zonnchen, P. Schwarz, U. Hock, J.H. Growdon and R.M. Nitsch, Increased blood mercury levels in patients with Alzheimer's disease, J. Neural Transm. 105 (1998), 59-68.
120. A. Hofman, A. Ott, M.M. Breteler, M.L. Bots, A.J. Slooter, F. van Harskamp, C.M. van Duijn, C. Van Broeckhoven and D.E. Grobbee, Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study, Lancet 349 (1997), 151-154.
121. K. Honda, G. Casadesus, R.B. Petersen, G. Perry and M.A Smith, Oxidative stress and redox-active iron in Alzheimer's disease. Ann. N. Y. Acad. Sci. 1012 (2004), 179-182.
122. E. House, J. Collingwood, A. Khan, O. Korchazkina, G. Berthon and C. Exley, Aluminium, iron, zinc and copper influence the in vitro formation of amyloid fibrils of Abeta42 in a manner which may have consequences for metal chelation therapy in Alzheimer's disease, J. Alzheimers Dis. 6 (2004), 291-301, 35.
123. J.M. Howard, Clinical import of small increases in serum aluminium, Clin. Chem. 30 (1984), 1722-1723.
124. S. Hoyer, Is sporadic Alzheimer disease the brain type of non-insulin dependent diabetes mellitus? A challenging hypothesis, J. Neural Transm. 105 (1998), 415-422.
125. S. Hoyer, The brain insulin signal transduction system and sporadic (type II) Alzheimer disease: an update, J. Neural Transm. 109 (2002), 341-360.
126. F.B. Hu, L. Bronner, W.C. Willett, M.J. Stampfer, K.M. Rexrode, C.M. Albert, D. Hunter and J.E. Manson, Fish and omega-3 fatty acid intake and risk of coronary heart disease in women, J.A.M.A. 287 (2002), 1815-1821.
127. P.P. Huijbregts, E.J. Feskens, L. Rasanen, A. Alberti-Fidanza, M. Mutanen, F. Fidanza and D. Kromhout, Dietary intake in five ageing cohorts of men in Finland, Italy, and the Netherlands, Eur. J. Clin. Nutr. 49 (1995), 852-860.
128. P.P. Huijbregts, E.J. Feskens, L. Rasanen, F. Fidanza, A. Alberti-Fidanza, A. Nissinen, S. Giampaoli and D. Kromhout, Dietary patterns and cognitive function in elderly men in Finland, Italy, and the Netherlands, Eur. J. Clin. Nutr. 52 (1998), 826-831.
129. W. Huang, C. Qiu, B. Winblad and L. Fratiglioni, Alcohol consumption and incidence of dementia in a community sample aged 75 years and older, J. Clin. Epidemiol. 55 (2002), 959-964.
130. H. Jacqmin, D. Commenges, L. Letenneur, P. Barberger-Gateau and J.F. Dartigues, Components of drinking water and risk of cognitive impairment in the elderly, Am. J. Epidemiol. 139 (1994), 48-57.
131. H. Jacqmin-Gadda, D. Commenges, L. Letenneur and J.F. Dartigues, Silica and aluminum in drinking water and cognitive impairment in the elderly, Epidemiology 7 (1996), 281-285.
132. M.J. Jarvis, Does caffeine enhance absolute levels of cognitive performance?, Psychopharmacology 110 (1993), 45-52.
133. A.P. Jayasooriya, M.L. Ackland, M.L. Mathai, A.J. Sinclair, H.S. Weisinger, R.S. Weisinger, J.E. Halver, K. Kitajka and L.G. Puskas, Perinatal omega-3 polyunsaturated fatty acid supply modifies brain zinc homeostasis during adulthood, Proc. Natl. Acad. Sci. USA. 102 (2005), 133-138.
134. B.L. Jorissen and W.J. Riedel, Nutrients, age and cognition, Clin. Nutr. 21 (2002), 89-95.
135. C.B. Jones, T. Arai and S.I. Rapoport, Evidence for the involvement of docosahexaenoic acid in cholinergic stimulated signal transduction at the synapse, Neurochem. Res. 22 (1997), 663-670.
136. A.F. Jorm, C.M. van Duijn, V. Chandra, L. Fratiglioni, A. Heyman, E. Kokmen, K. Kondo, J.A. Mortimer, W.A. Rocca, S.L. Shalat, H. Soininen and A. Hofman, Psychiatric history and related exposures as risk factors for Alzheimer's disease: A collaborative reanalysis of case-control studies, Int. J. Epidemiol. 20 (1991), S43-S47.
137. A.F. Jorm, Is depression a risk factor for dementia or cognitive decline?, Gerontology 46 (2000), 219-227.
138. J.A. Joseph, B. Shukitt-Hale, N.A. Denisova, D. Bielinski, A. Martin, J.J. McEwen and P.C. Bickford, Reversals of age-related declines in neuronal signal-transduction, cognitive and motor behavioral deficits with blueberry, spinach or strawberry, dietary supplementation, J. Neurosci. 19 (1999), 8114-8121.
139. W.H. Kaye, H.E. Gwirtsman, T.D. Brewerton, D.T. George and R.J. Wurtman, Bingeing behavior and plasma amino acids: a possible involvement of brain serotonin in bulimia nervosa, Psychiatry Res. 23 (1988), 31-43.
140. S. Kalmijn, E.J. Feskens, L.J. Launer and D. Kromhout, Polyunsaturated fatty acids, antioxidants, and cognitive functions in very old men, Am. J. Epidemiol. 145 (1997), 33-41.
141. S. Kalmijn, L.J. Launer, A. Ott, J.C. Witteman, A. Hofman and M.M. Breteler, Dietary fat intake and the risk of incident dementia in the Rotterdam study, Ann. Neurol. 42 (1997), 776-782.
142. S. Kalmijn, M.P.J. van Boxtel, M.V.M. Verschuren, J. Jolles and L.J. Launer, Cigarette smoking and alcohol consumption in relation to cognitive performance in middle age, Am. J. Epidemiol. 156 (2002), 936-944.
143. R. Kanarek, Psychological effects of snacks and altered meal frequency, Br. J. Nutr. 77 (1997), S105-S120.
144. A. Kontush, Amyloid-beta: an antioxidant that becomes a pro-oxidant and critically contributes to Alzheimer's disease, Free Radic. Biol. Med. 31 (2001), 1120-1131.
145. R.J. Kaplan, C.E. Greenwood, G. Winocur and T.M. Wolever, Cognitive performance is associated with glucose regulation in healthy elderly persons and can be enhanced with glucose and dietary carbohydrates, Am. J. Clin. Nutr. 72 (2000), 825-836.
146. R.J. Kaplan, C.E. Greenwood, G. Winocur and T.M. Wolever, Dietary protein, carbohydrate, and fat enhance memory performance in the healthy elderly, Am. J. Clin. Nutr. 74 (2001), 687-693.
147. M.D. Kopelman and N. Stanhope, Rates of forgetting in organic amnesia following temporal lobe, diencephalic, or frontal lobe lesions, Neuropsychology 11 (1997), 343-356.
148. D.L. Korol and P.E. Gold, Glucose, memory, and aging, Am. J. Clin. Nutr. 67(Suppl) (1998), 764S-771S.
149. I.I. Kruman, T.S. Kumaravel, A. Lohani, W.A. Pedersen, R.G. Cutler, Y. Kruman, N. Haughey, J. Lee, M. Evans and M.P. Mattson, Folic acid deficiency and homocysteine impair DNA repair in hippocampal neurons and sensitize them to amyloid toxicity in experimental models of Alzheimer's disease, J. Neurosci. 22 (2002), 1752-1762.
150. S.J. Langan, I.J. Deary, D.A. Hepburn and B.M. Frier, Cumulative cognitive impairment following recurrent severe hypoglycaemia in adult patients with insulin-treated diabetes mellitus, Diabetologia 34 (1991), 337-344.
151. A. La Rue, K.M. Koehler, S.J. Wayne, S.J. Chiulli, K.Y. Haaland and P.J. Garry, Nutritional status and cognitive functioning in a normally aging sample: a 6-y reassessment, Am. J. Clin. Nutr. 65 (1997), 20-29.
152. S. Larrieu, L. Letenneur, C. Helmer, J.F. Dartigues and P. Barberger-Gateau, Nutritional factors and risk of incident dementia in the PAQUID longitudinal cohort, J. Nutr. Health Aging. 8 (2004), 150-154.
153. L.J. Launer, E.J. Feskens, S. Kalmijn and D. Kromhout, Smoking, drinking, and thinking. The Zutphen Elderly Study, Am. J. Epidemiol. 143 (1996), 219-227.
154. J.Y. Lee, T.B. Cole, R.D. Palmiter, S.W. Suh and J.Y. Koh, Contribution by synaptic zinc to the gender-disparate plaque formation in human Swedish mutant APP transgenic mice, Proc. Natl. Acad. Sci. USA. 99 (2002), 7705-7710.
155. D. Leibovici, K. Ritchie, B. Ledesert and J. Touchon, The effects of wine and tobacco consumption on cognitive performance in the elderly: a longitudinal study of relative risk, Int. J. Epidemiol. 28 (1999), 77-81.
156. I. Leroi, J.M. Sheppard and C.G. Lyketsos, Cognitive function after 11.5 years of alcohol use: relation to alcohol use, Am. J. Epidemiol. 156 (2002), 747-752.
157. R. Levy, Aging-associated cognitive decline. Working Party of the International Psychogeriatric Association in collaboration with the World Health Organization, Int. Psychogeriatrics 6 (1994), 63-68.
158. H.M. Lloyd and P.J. Rogers, Mood and cognitive performance improved by a small amount of alcohol given with a lunchtime meal, Behav. Pharmacol. 8 (1997), 188-195.
159. J. Lindsay, D. Laurin, R. Verreault, R. Hebert, B. Helliwell, G.B. Hill and I. McDowell, Risk factors for Alzheimer's disease: a prospective analysis from the Canadian study of health and aging, Am. J. Epidemiol. 156 (2002), 445-453.
160. A. Lione, Aluminum toxicology and the aluminumcontaining medications, Pharmacol. Ther. 29 (1985), 255-285.
161. B. Lonnerdal, Dietary factors influencing zinc absorption, J. Nutr. 130(Suppl 5) (2000), 1378S-1383S.
162. M.A. Lovell, W.D. Ehmann, W.R. Markesbery, S. Melethil, C.R. Swyt and P.F. Zatta, Standardization in biological analyses of aluminum: What are the needs?, J. Toxicol. Environ. Health 48 (1996), 637-648.
163. M.A. Lovell, J.D. Robertson, W.J. Teesdale, J.L. Campbell and W.R. Markesbery, Copper, iron and zinc in Alzheimer's disease senile plaques, J. Neurol. Sci. 158 (1998), 47-52.
164. M.A. Lovell, C. Xie and W.R. Markesbery, Protection against amyloid beta peptide toxicity by zinc, Brain Res. 823 (1999), 88-95.
165. J.A. Luchsinger, M.X. Tang, S. Shea and R. Mayeux, Caloric intake and the risk of Alzheimer disease, Arch. Neurol. 59 (2002), 1258-1263.
166. J.A. Luchsinger and R. Mayeux, Dietary factors and Alzheimer's disease, Lancet Neurol. 3 (2004), 579-587.
167. J.A. Luchsinger, M.X. Tang, M. Siddiqui, S. Shea and R. Mayeux, Alcohol intake and risk of dementia, J. Am. Geriatr. Soc. 52 (2004), 540-546.
168. K.M. MacLeod, A.E. Gold, K.P. Ebmeier, D.A. Hepburn, I.J. Deary, G.M. Goodwin and B.M. Frier, The effects of acute hypoglycemia on relative cerebral blood flow distribution in patients with type I (insulin-dependent) diabetes and impaired hypoglycemia awareness, Metabolism 45 (1996), 974-980.
169. R.W. Mahley and S.C. Rall, Jr., Apolipoprotein E: far more than a lipid transport protein, Annu. Rev. Genomics Hum. Genet. 1 (2000), 507-537.
170. L. Maia and A. de Mendonca, Does caffeine intake protect from Alzheimer's disease?, Eur. J. Neurol. 9 (2002), 377-382.
171. D.C. Martin, J. Francis, J. Protetch and F.J. Huff, Time dependency of cognitive recovery with cobalamin replacement: report a pilot study, J. Am. Geriatr. Soc. 40 (1992), 168-172.
172. A. Martin, R. Prior, B. Shukitt-Hale, G. Cao and J.A. Joseph, Effects of fruits, vegetables or vitamin E rich diet on vitamins E and C distribution in peripheral and brain tissues: implications for brain function, J. Gerontol. A Biol. Sci. Med. Sci. 55 (2000), B144-B151.
173. C.N. Martyn, C. Osmond, J.A. Edwardson, D.J.P. Barker, E.C. Harris and R.F. Lacey, Geographical relation between Alzheimer's disease and aluminium in drinkingwater, Lancet 1 (1989), 59-62.
174. C.N. Martyn, D.N. Coggon, H. Inskip, R.F. Lacey and W.F. Young, Aluminium concentrations in drinking water and risk of Alzheimer's disease, Epidemiology 8 (1997), 281-286.
175. C.A. Manning, J.L. Hall and P.E. Gold, Glucose effects on memory and other neuropsychological tests in elderly humans, Psychol. Sci. 1 (1990), 307-311.
176. C.A. Manning, M.W. Parsons, E.M. Cotter and P.E. Gold, Glucose effects on declarative and nondeclarative memory in healthy elderly and young adults, Psychobiology 25 (1997), 103-108.
177. R. Mayeux, A.M. Saunders, S. Shea, S. Mirra, D. Evans, A.D. Roses, B.T. Hyman, B. Crain, M.X. Tang and C.H. Phelps, Utility of the apolipoprotein E genotype in the diagnosis of Alzheimer's disease. Alzheimer's Disease Centers Consortium on Apolipoprotein E and Alzheimer's Disease, N. Engl. J. Med. 338 (1998), 506-511.
178. R.J. McCrimmon, I.J. Deary, B.J. Huntly, K.J. MacLeod and B.M. Frier, Visual information processing during controlled hypoglycaemia in humans, Brain 119 (1996), 1277-1287.
179. D.R. McLachlan, P.E. Fraser and A.J. Dalton, Aluminium and the pathogenesis of Alzheimer's disease: a summary of evidence, Ciba Found. Symp. 169 (1992), 87-98.
180. D.R. McLachlan, W.L. Smith and T.P. Kruck. Desferrioxamine and Alzheimer's disease: video home behavior assessment of clinical course and measures of brain aluminum, Ther. Drug Monit. 15 (1993), 602-607.
181. D.R. McLachlan, Aluminium and the risk for Alzheimer's disease, Environmetrics 6 (1995), 233-275.
182. D.R. McLachlan, C. Bergeron, J.E. Smith, D. Boomer and S.L. Rifat, Risk for neuropahologically confirmed Alzheimer's disease and residual aluminium in municipal drinking water employing weighted residential histories, Neurology 46 (1996), 401-405.
183. C. Messier and M. Gagnon, Glucose regulation and cognitive functions: relation to Alzheimer's disease and diabetes, Behav. Brain Res. 75 (1996), 1-11.
184. C. Messier, T. Durkin, O. Mrabet and C. Destrade, Memory-improving action of glucose: indirect evidence for a facilitation of hippocampal acetylcholine synthesis, Behav. Brain Res. 39 (1990), 135-143.
185. P. Michel, D. Commenges, J.F. Dartigues, M. Gagnon, P. Barberger-Gateau and L. Letenneur, Study of the relationship between aluminium concentration in drinking water and risk of Alzheimer's disease, in: Alzheimer's disease: Basic mechanisms, diagnosis and therapeutic strategies, K. Iqbal, D.R. McLachlan, B. Winblad and H.M. Wisniewski, eds, Chichester: John Wiley, 1991, pp. 387-391.
186. K. Millar, R.H. Hammersley and F. Finnigan, Reduction of alcohol-induced performance impairment by prior ingestion of food, Br. J. Psychol. 83(Pt 2) (1992), 261-278.
187. R. Mielke, H.J. Moller, T. Erkinjuntti, B. Rosenkranz, M. Rother and B. Kittner, Propentofylline in the treatment of vascular dementia and Alzheimer-type dementia: overview of phase I and phase II clinical trials, Alzheimer Dis. Assoc. Disord. 12(Suppl 2) (1998), S29-S35.
188. A.C. Miu, C.E. Andreescu, R. Vasiu and A.I. Olteanu, A behavioral and histological study of the effects of long-term exposure of adult rats to aluminum, Int. J. Neurosci. 113(2003), 1197-1211.
189. A.C. Miu, A.I. Olteanu and M. Miclea, A behavioral and ultrastructural dissection of the interference of aluminum with aging, J. Alzheimers Dis. 6 (2004), 315-328.
190. J.A. Molina, F.J. Jimenez-Jimenez, M.V. Aguilar, I. Meseguer, C.J. Mateos-Vega, M.J. Gonzalez-Munoz, F. de Bustos, J. Porta, M. Orti-Pareja, M. Zurdo, E. Barrios and M.C. Martinez-Para, Cerebrospinal fluid levels of transition metals in patients with Alzheimer's disease, J. Neural Transm. 105 (1998), 479-488.
191. R.D. Moir, C.S. Atwood, D.M. Romano, M.H. Laurans, X. Huang, A.I. Bush, J.D. Smith and R.E. Tanzi, Differential effects of apolipoprotein E isoforms on metal-induced aggregation of A beta using physiological concentrations, Biochemistry. 38 (1999), 4595-4603.
192. P. Moreira, C. Pereira, M.S. Santos and C. Oliveira, Effect of zinc ions on the cytotoxicity induced by the amyloid beta-peptide, Antioxid. Redox Signal. 2 (2000), 317-325.
193. P.I. Moreira, M.A. Smith, X. Zhu, M.S. Santos, C.R. Oliveira and G. Perry, Therapeutic potential of oxidant mechanisms in Alzheimer's disease, Expert Rev. Neurother. 4 (2004), 995-1004.
194. P.I. Moreira, S.L. Siedlak, G. Aliev, X. Zhu, A.D. Cash, M.A. Smith and G. Perry, Oxidative stress mechanisms and potential therapeutics in Alzheimer disease, J. Neural Transm. 112 (2005), 921-932.
195. J.E. Morley, J.F. Flood, A.J. Silver and F.E. Kaiser, Effects of peripherally secreted hormones on behaviour, Neurobiol. Aging 15 (1994), 573-577.
196. J.C. Morris, The Clinical Dementia Rating (CDR): current version and scoring rules, Neurology 43 (1993), 2412-2414.
197. J.C. Morris, M. Storandt, P. Miller, D.W. McKeel, J.L. Price, E.H. Rubin and L. Berg, Mild cognitive impairment represents early-stage Alzheimer disease, Arch. Neurol. 58 (2001), 397-405.
198. M.S. Morris, Folate, homocysteine, and neurological function, Nutr. Clin. Care 5 (2002), 124-132.
199. M.S. Morris, Homocysteine and Alzheimer's disease, Lancet Neurol 2 (2003), 425-428.
200. M.C. Morris, D.A. Evans, J.L. Bienias, C.C. Tangney, D.A. Bennett, N. Aggarwal, J. Schneider and R.S. Wilson, Dietary fats and the risk of incident Alzheimer disease, Arch. Neurol. 60 (2003), 194-200.
201. M.C. Morris, D.A. Evans, J.L. Bienias, C.C. Tangney, D.A. Bennett, R.S. Wilson, N. Aggarwal and J. Schneider, Consumption of fish and n-3 fatty acids and risk of incident Alzheimer disease, Arch. Neurol. 60 (2003), 940-946.
202. K.J. Mukamal, L.H. Kuller, A.L. Fitzpatrick, W.T. Jr. Longstreth, M.A. Mittleman and D.S. Siscovick, Prospective study of alcohol consumption and risk of dementia in older adults, J.A.M.A. 289 (2003), 1405-1413.
203. G. Munch, R. Schinzel, C. Loske, A. Wong, N. Durany, J.J. Li, H. Vlassara, M.A. Smith, G. Perry and P. Riederer, Alzheimer's disease - synergistic effects of glucose deficit, oxidative stress and advanced glycation endproducts, J. Neural Transm. 105 (1998), 439-461.
204. D. Mungas, J.K. Cooper, P.G. Weiler, D. Gietzen, C. Franzi and C. Bernick, Dietary preference for sweet foods in patients with dementia, J. Am. Geriatr. Soc. 38 (1990), 999-1007.
205. J. Mutter, J. Naumann, C. Sadaghiani, R. Schneider and H. Walach, Alzheimer disease: mercury as pathogenetic factor and apolipoprotein E as a moderator, Neuro. Endocrinol. Lett. 25 (2004), 331-339.
206. L.C. Neri and D. Hewitt, Aluminium, Alzheimer's disease, and drinking water, Lancet 338 (1991), 390.
207. Neuropathology Group of the Medical Research Council Cognitive Function and Ageing Study (MRC CFAS), Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales, Lancet 357 (2001), 169-175.
208. E. Nieboer, B.L. Gibson, A.D. Oxman and J.R. Kramer, Health effects of aluminum: A critical review with emphasis on aluminum in drinking water, Environ. Rev. 3 (1995), 29-81.
209. S.J. Nixon, Alcohol, aging, and cognition, in: Alcohol Problems and Aging, E.S. Lisansky Gomberg, A.M. Hegedus and R.A. Zucker, eds, Bethesda, Md: National Institute on Alcohol Abuse and Alcoholism; NIH Publication, 1998, pp. 4163-4198.
210. J.M. Orgogozo, J.F. Dartigues, S. Lafont, L. Letenneur, D. Commenges, R. Salamon, S. Renaud and M.B. Breteler, Wine consumption and the elderly: a prospective community study in the Bordeaux area, Rev. Neur. 153 (1997), 185-192.
211. R.M. Ortega, A.M. Requejo, P. Andres, A.M. Lopez-Sobaler, M.E. Quintas, M.R. Redondo, B. Navia and T. Rivas, Dietary intake and cognitive function in a group of elderly people, Am. J. Clin. Nutr. 66 (1997), 803-809.
212. A. Ott, M.M. Breteler, M.C. de Bruyne, F. van Harskamp, D.E. Grobbee and A. Hofman, Atrial fibrillation and dementia in a population-based study. The Rotterdam Study, Stroke 28 (1997), 316-321.
213. A. Ott, R.P. Stolk, F. van Harskamp, H.A. Pols, A. Hofman and M.M. Breteler, Diabetes mellitus and the risk of dementia: The Rotterdam Study, Neurology 53 (1999), 1937-1942.
214. M. Otsuka, K. Yamaguchi and A. Ueki, Similarities and differences between Alzheimer's disease and vascular dementia from the viewpoint of nutrition, Ann. N. Y. Acad. Sci. 977 (2002), 155-161.
215. R. Ozcankaya and N. Delibas, Malondialdehyde, superoxide dismutase, melatonin, iron, copper and zinc blood concentrations in patients with Alzheimer disease: cross-sectional study. Croat. Med. J. 43 (2002), 28-32.
216. M. Paleologos, R.G. Cumming and R. Lazarus, Cohort study of vitamin C intake and cognitive impairment, Am. J. Epidemiol. 148 (1998), 45-50.
217. F. Panza, A. D'Introno, A.M. Colacicco, A.M. Basile, C. Capurso, P.G. Kehoe, A. Capurso and V. Solfrizzi, Vascular risk and genetics of sporadic late-onset Alzheimer's disease, J. Neural Transm. 111 (2004), 69-89.
218. F. Panza, V. Solfrizzi, A. D'Introno, S. Capurso and A. Capurso, The role of micronutrients in cognitive decline and dementia, in: Diet and Cognitive Decline, F. Panza, V. Solfrizzi and A. Capurso, eds, Nova Science Publishers, Inc.: 2004, NY, USA, pp. 35-58.
219. F. Panza, A. D'Introno, A.M. Colacicco, C. Capurso, A. Del Parigi, R.J. Caselli, A. Pilotto, G. Argentieri, P.L. Scapicchio, E. Scafato, A. Capurso and V. Solfrizzi, Current epidemiology of mild cognitive impairment and other predementia syndromes, Am. J. Geriatr. Psychiatry 13 (2005), 633-644.
220. F. Panza, A. D'Introno, A.M. Colacicco, C. Capurso, A. Del Parigi, S.A. Capurso, R.J. Caselli, A. Pilotto, E. Scafato, A. Capurso and V. Solfrizzi, Cognitive frailty: Predementia syndrome and vascular risk factors, Neurobiol. Aging 27 (2006), 933-940.
221. F. Panza and C. Capurso, Solfrizzi, Cardiovascular factors and cognitive impairment: a role for unsaturated fatty acids and mediterranean diet?, Am. J. Cardiol. (2006), in press.
222. F. Panza, C. Capurso, A. D'Introno, A.M. Colacicco, A. Del Parigi, A. Gadaleta, A. Capurso and V. Solfrizzi, Possible Role of Unsaturated Fatty Acids in a 14-Day Healthy Longevity Lifestyle Program, Am. J. Geriatr. Psychiatry (2006), in press.
223. M.W. Parsons and P.E. Gold, Glucose enhancement of memory in elderly humans: an inverted-U dose-response curve, Neurobiol. Aging 13 (1992), 401-104.
224. W.J. Perrig, P. Perrig and B. Stehelin, The relation between antioxidants and memory performance in the old and very old, J. Am. Geriatr. Soc. 45 (1997), 718-724.
225. A.J. Perkins, H.C. Hendrie, C.M. Callahan, S. Gao, F.W. Unverzagt, Y. Xu, K.S. Hall and S.L. Hui, Association of antioxidants with memory in a multiethnic elderly sample using the Third National Health and Nutrition Examination Survey, Am. J. Epidemiol. 150 (1999), 37-44.
226. R.C. Petersen, G.E. Smith, S.C. Waring, R.J. Ivnik, E.G. Tangalos and E. Kokmen, Mild cognitive impairment: clinical characterization and outcome, Arch. Neurol. 56 (1999), 303-308.
227. R.C. Petersen, R. Doody, A. Kurz, R.C. Mohs, J.C. Morris, P.V. Rabins, K. Ritchie, M. Rossor, L. Thal and B. Winblad, Current concepts in mild cognitive impairment, Arch. Neurol. 58 (2001), 1985-1992.
228. A.L. Phinney, B. Drisaldi, S.D. Schmidt, S. Lugowski, V. Coronado, Y. Liang, P. Horne, J. Yang, J. Sekoulidis, J. Coomaraswamy, M.A. Chishti, D.W. Cox, P.M. Mathews, R.A. Nixon, G.A. Carlson, P.S. George-Hyslop and D. Westaway, In vivo reduction of amyloid-{beta} by a mutant copper transporter, Proc. Natl. Acad. Sci. USA. 100 (2003), 14193-14198.
229. F.C. Potocnik, S.J. van Rensburg, C. Park, J.J. Taljaard and R.A. Emsley, Zinc and platelet membrane microviscosity in Alzheimer's disease. The in vivo effect of zinc on platelet membranes and cognition, S. Afr. Med. J. 87 (1997), 116-119.
230. A. Pradignac, J.L. Schlienger, M. Velten and L. Mejean, Relationships between macronutrient intake, handicaps, and cognitive impairments in free living elderly people, Aging Clin. Exp. Res. 7 (1995), 67-74.
231. A.S. Prasad, Clinical, biochemical and nutritional spectrum of zinc deficiency in human subjects: an update, Nutr. Rev. 41 (1983), 197-208.
232. P. Quadri, C. Fragiacomo, R. Pezzati, E. Zanda, G. Forloni, M. Tettamanti and U. Lucca, Homocysteine, folate, and vitamin B-12 in mild cognitive impairment, Alzheimer disease, and vascular dementia, Am. J. Clin. Nutr. 80 (2004), 114-122.
233. M.E. Ragozzino, S.N. Pal, K. Unick, M.R. Stefani and P.E. Gold, Modulation of hippocampal acetylcholine release and spontaneous alternation scores by intrahippocampal glucose injections, J. Neurosci. 18 (1998), 1595-1601.
234. A.L. Rauma and H. Mykkanen, Antioxidant status in vegetarians versus omnivores, Nutrition 16 (2000), 111-119.
235. M. Reding, J. Haycox and J. Blass, Depression in patients referred to a dementia clinic, Arch. Neurol. 42 (1985), 894-896.
236. B. Regland, W. Lehmann, I. Abedini, K. Blennow, M. Jonsson, I. Karlsson, M. Sjogren, A. Wallin, M. Xilinas and C.G. Gottfries, Treatment of Alzheimer's disease with clioquinol, Dement. Geriatr. Cogn. Disord. 12 (2001), 408-414.
237. W.J. Riedel and B.L. Jorissen, Nutrients, age and cognitive function, Curr. Opin. Clin. Nutr. Metab. Care 1 (1998), 579-585.
238. C.W. Ritchie, A.I. Bush, A. Mackinnon, S. Macfarlane, M. Mastwyk, L. MacGregor, L. Kiers, R. Cherny, Q.X. Li, A. Tammer, D. Carrington, C. Mavros, I. Volitakis, M. Xilinas, D. Ames, S. Davis, K. Beyreuther, R.E. Tanzi and C.L. Masters, Metal-protein attenuation with iodochlorhydroxyquin (clioquinol) targeting Abeta amyloid deposition and toxicity in Alzheimer disease: a pilot phase 2 clinical trial, Arch. Neurol. 60 (2003), 1685-1691.
239. K.M. Riggs, A. Spiro, 3rd., K. Tucker and D. Rush, Relations of vitamin B-12, vitamin B-6, folate, and homocysteine in cognitive performance in the Normative Aging Study, Am. J. Clin. Nutr. 63 (1996), 306-314.
240. N.B. Roberts, A. Clough, J.P. Bellia and J.Y. Kim, Increased absorption of aluminium from a normal dietary intake in dementia. J. Inorg. Biochem. 69 (1998), 171-176.
241. E.I. Rogaev, R. Sherrington, E.A. Rogaeva, G. Levesque, M. Ikeda, Y. Liang, H. Chi, C. Lin, K. Holman, T. Tsuda, L. Mar, S. Sorbi, B. Nacmias, S. Piacentini, I. Chumakov, D. Cohen, L. Lannfelt, P.E. Fraser, J.M. Rommens and P.H. St. George-Hyslop, Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene, Nature 376 (1995), 775-778.
242. J.T. Rogers, J.D. Randall, C.M. Cahill, P.S. Eder, X. Huang, H. Gunshin, L. Leiter, J. McPhee, S.S. Sarang, T. Utsuki, N.H. Greig, D.K. Lahiri, R.E. Tanzi, A.I. Bush, T. Giordano and S.R. Gullans, An iron-responsive element type II in the 5′-untranslated region of the Alzheimer's amyloid precursor protein transcript, J. Biol. Chem. 277 (2002), 45518-45528.
243. M.A. Rogers and D.G. Simon, A preliminary study of dietary aluminium intake and risk of Alzheimer's disease, Age Ageing 28 (1999), 205-209.
244. R.D. Rogers, B.J. Everitt, A. Baldacchino, A.J. Blackshaw, R. Swainson, K. Wynne, N.B. Baker, J. Hunter, T. Carthy, E. Booker, M. London, J.F. Deakin, B.J. Sahakian and T.W. Robbins, Dissociable deficits in the decision-making cognition of chronic amphetamine abusers, opiate abusers, patients with focal damage to prefrontal cortex, and tryptophan-depleted normal volunteers: evidence for monoaminergic mechanisms, Neuropsychopharmacology 20 (1999), 322-339.
245. G.C. Roman and D.R. Royall, Executive control function: a rational basis for the diagnosis of vascular dementia, Alzheimer Dis. Assoc. Disord. 13(Suppl. 3) (1999), S69-S80.
246. G.C. Roman, Defining dementia: clinical criteria for the diagnosis of vascular dementia, Acta Neurol. Scand. Suppl. 178 (2002), 6-9.
247. G.C. Roman, P. Sachdev, D.R. Royall, R.A. Bullock, J.M. Orgogozo, S. Lopez-Pousa, R. Arizaga and A. Wallin, Vascular cognitive disorder: a new diagnostic category updating vascular cognitive impairment and vascular dementia, J. Neurol. Sci. 226 (2004), 81-87.
248. V. Rondeau, D. Commenges, H. Jacqmin-Gadda and J.F. Dartigues, Relation between aluminium concentrations in drinking water and Alzheimer's disease: An 8-year follow-up study. Am. J Epidemiol. 152 (2000), 59-66.
249. G.W. Ross, H. Petrovitch, L.R. White, K.H. Masaki, C.Y. Li, J.D. Curb, K. Yano, B.L. Rodriguez, D.J. Foley, P.L. Blanchette and R. Havlik, Characterization of risk factors for vascular dementia. The Honolulu-Asia Aging Study, Neurology 53 (1999), 337-343.
250. G.W. Ross, R.D. Abbott, H. Petrovitch, D.M. Morens, A. Grandinetti, K.H. Tung, C.M. Tanner, K.H. Masaki, P.L. Blanchette, J.D. Curb, J.S. Popper and L.R. White, Association of coffee and caffeine intake with the risk of Parkinson disease, J.A.M.A. 283 (2000), 2674-2679.
251. A. Ruitenberg, J.C. van Swieten, J.C. Witteman, K.M. Mehta, C.M. van Duijn, A. Hofman and M.M. Breteler, Alcohol consumption and risk of dementia: the Rotterdam Study, Lancet 359 (2002), 281-286.
252. L.L. Rulon, J.D. Robertson, M.A. Lovell, M.A. Deibel, W.D. Ehmann and W.R. Markesber, Serum zinc levels and Alzheimer's disease, Biol. Trace Elem. Res. 75 (2000), 79-85.
253. P. Sachdev, Vascular cognitive disorder, Int. J. Geriatr. Psychiatry 14 (1999), 402-403.
254. M. Sano, C. Ernesto, R.G. Thomas, M.R. Klauber, K. Schafer, M. Grundman, P. Woodbury, J. Growdon, C.W. Cotman, E. Pfeiffer, L.S. Schneider and L.J. Thal, A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease, N. Engl. J. Med. 336 (1997), 1216-1222.
255. R.M. Sapolsky, Stress, the aging brain, and the mechanisms of neuron death, Cambridge, MIT Press, 1992.
256. A.M. Saunders, W.J. Strittmatter, D. Schmechel, P.H. St. George-Hyslop, M.A. Pericak-Vance, S.H. Joo, B.L. Rosi, J.F. Gusella, D.R. Crapper-MacLachlan, M.J. Alberts, C. Huletta, B. Crain, D. Goldgaber and A.D. Roses, Association of apolipoprotein E allele e4 with late-onset familial and sporadic Alzheimer's disease, Neurology 43 (1993), 1467-1472.
257. J. Savory, C. Exley, W.F. Forbes, Y. Huang, J.G. Joshi, T. Kruck, D.R. McLachlan and I. Wakayama, Can the controversy of the role of aluminum in Alzheimer's disease be resolved? What are the suggested approaches to this controversy and methodological issues to be considered?, J. Toxicol. Environ. Health 48 (1996), 615-635.
258. N. Scarmeas, Y. Stern, M.X. Tang, R. Mayeux and J.A. Luchsinger, Mediterranean diet and risk for Alzheimer's disease, Ann. Neurol. 59 (2006), 912-921.
259. M. Serafini, G. Maiani and A. Ferro-Luzzi, Alcohol-free red wine enhances plasma antioxidant capacity in humans, J. Nutr. 128 (1998), 1003-1007.
260. S. Seshadri, A. Beiser, J. Selhub, P.F. Jacques, I.H. Rosenberg, R.B. D'Agostino, P.W. Wilson and P.A. Wolf, Plasma homocysteine as a risk factor for dementia and Alzheimer's disease, N. Engl. J. Med. 346 (2002), 476-483.
261. R. Sherrington, E.I. Rogaev, Y. Liang, E.A. Rogaeva, G. Levesque, M. Ikeda, H. Chi, C. Lin, G. Li, K. Holman, T. Tsuda, L. Mar, J.F. Foncin, A.C. Bruni, M.P. Montesi, S. Sorbi, I. Rainero, L. Pinessi, L. Nee, I. Chumakov, D. Pollen, A. Brookes, P. Sansosu, R.J. Polinsky, W. Wasco, H.A.R. Da Silva, J.L. Haines, M.A. Pericak-Vance, R.E. Tanzi, A.D. Roses, P.E. Fraser, J.M. Rommens and P. St George-Hyslop, Cloning of a novel gene bearing missense mutations in early onset familial Alzheimer's disease, Nature 375 (1995), 754-760.
262. I. Skoog, B. Lernfelt, S. Landahl, B. Palmertz, L.A. Andreasson, L. Nilsson, G. Persson, A. Oden and A. Svanborg, 15-year longitudinal study of blood pressure and dementia, Lancet 347 (1996), 1141-1145.
263. G.W. Small, D.H. Silverman, P. Siddarth, L.M. Ercoli, K.J. Miller, H. Lavretsky, B.C. Wright, S.Y. Bookheimer, J.R. Barrio and M.E. Phelps, Effects of a 14-day healthy longevity lifestyle program on cognition and brain function, Am. J. Geriatr. Psychiatry 14 (2006), 538-545.
264. C. Smorgon, E. Mari, A.R, Atti, E. Dalla Nora, P.F. Zamboni, F. Calzoni, A. Passaro and R. Fellin, Trace elements and cognitive impairment: an elderly cohort study, Arch. Gerontol. Geriatr. Suppl. 9 (2004), 393-402.
265. J. Snaedal, J. Kristinsson, S. Gunnarsdottir, Olafsdottir, M. Baldvinsson and T. Johannesson, Copper ceruloplasmin and superoxide dismutase in patients with Alzheimer's disease, a case-control study, Dement. Geriatr Cogn Disord. 9 (1998), 239-242.
266. V. Solfrizzi, F. Panza, F. Torres, F. Mastroianni, A. Del Parigi, A. Venezia and A. Capurso, High monounsaturated fatty acids intake protects against age-related cognitive decline, Neurology 52 (1999), 1563-1569.
267. V. Solfrizzi, F. Panza and A. Capurso, The role of diet in cognitive decline, J. Neural Transm. 110 (2003), 95-110.
268. V. Solfrizzi, F. Panza, A.M. Colacicco, A. D'Introno, C. Capurso, F. Torres, F. Grigoletto, S. Maggi, A. Del Parigi, E.M. Reiman, R.J. Caselli, E. Scafato, G. Farchi and A. Capurso, Italian Longitudinal Study on Aging Working Group, Vascular risk factors, incidence of MCI, and rates of progression to dementia, Neurology 63 (2004), 1882-1891.
269. V. Solfrizzi, A. D'Introno, A.M. Colacicco, C. Capurso, A. Del Parigi, S. Capurso, A. Gadaleta, A. Capurso and F. Panza, Dietary fatty acids intake: possible role in cognitive decline and dementia, Exp. Gerontol. 40 (2005), 257-270.
270. V. Solfrizzi, A.M. Colacicco, A. D'Introno, C. Capurso, F. Torres, C. Rizzo, A. Capurso and F. Panza, Dietary intake of unsaturated fatty acids and age-related cognitive decline: a 8.5-year follow-up of the Italian Longitudinal Study on Aging, Neurobiol. Aging (2005) [Epub ahead of print]; DOI:10.1016/j.neurobiolaging.2005.09.026.
271. V. Solfrizzi, A.M. Colacicco, A. D'Introno, C. Capurso, A.D. Parigi, S.A. Capurso, G. Argentieri, A. Capurso and F. Panza, Dietary fatty acids intakes and rate of mild cognitive impairment. The Italian Longitudinal Study on Aging, Exp. Gerontol. 41 (2006), 619-627.
272. V. Solfrizzi, C. Capurso and F. Panza, Adherence to a Mediterranean dietary pattern and risk for Alzheimer's disease, Ann. Neurol. (2006), in press.
273. V. Solfrizzi, C. Capurso, A. D'Introno, A.M. Colacicco, A. Capurso and F. Panza, Whole-diet approach and risk of chronic disease: limits and advantages, J. Am. Geriatr. Soc. (2006), in press.
274. D.L. Sparks and B.G. Schreurs, Trace amounts of copper in water induce beta-amyloid plaques and learning deficits in a rabbit model of Alzheimer's disease, Proc. Natl. Acad. Sci. USA. 100 (2003), 11065-11069.
275. R. Squitti, D. Lupoi, P. Pasqualetti, G. Dal Forno, F. Vernieri, P. Chiovenda, L. Rossi, M. Cortesi, E. Cassetta and P.M. Rossigni, Elevation of serum copper levels in Alzheimer's disease, Neurology. 59 (2002), 1153-11561.
276. R. Squitti, P. Pasqualetti, E. Cassetta, G. Dal Forno, S. Cesaretti, F. Pedace, A. Finazzi-Agro and P.M. Rossigni, Elevation of serum copper levels discriminates Alzheimer's disease from vascular dementia, Neurology. 60 (2003), 2013-2014.
277. R. Squitti, P. Pasqualetti, G. Dal Forno, F. Moffa, E. Cassetta, D. Lupoi, F. Vernieri, L. Rossi, M. Baldassini and P.M. Rossigni, Excess of serum copper not related to ceruloplasmin in Alzheimer disease, Neurology. 64 (2005), 1040-1046.
278. M.W. Strachan, I.J. Deary, F.M. Ewing and B.M. Frier, Is type II diabetes associated with an increased risk of cognitive dysfunction? A critical review of published studies, Diabetes Care 20 (1997), 438-445.
279. G.A. Taylor, A.J. Newens, J.A. Edwardson, D.W.K. Kay and D.P. Forster, Alzheimer's disease and the relationship between silicon and aluminium in water supplies in northern England, J. Epidemiol. Community Health 49 (1995), 323-324.
280. K.L. Teff, S.N. Young and J.E. Blundell, The effect of protein or carbohydrate breakfasts on subsequent plasma amino acid levels, satiety and nutrient selection in normal males, Pharmacol. Biochem. Behav. 34 (1989), 829-837.
281. B.M. Todorich and J.R. Connor, Redox metals in Alzheimer's disease, Ann. N. Y. Acad. Sci. 1012 (2004), 171-178.
282. T. Truelsen, D. Thudium and M. Grønbæk, Amount and type of alcohol and risk of dementia: the Copenhagen city heart study, Neurology 59 (2002), 1313-1319.
283. A. Trichopoulou, A. Kouris-Blazos, M.L. Wahlqvist, C. Gnardellis, P. Lagiou, E. Polychronopoulos, T. Vassilakou, L. Lipworth and D. Trichopoulos, Diet and overall survival in elderly people, B.M.J. 311 (1995), 1457-1460.
284. D.M. Tucker, J.G. Penland, H.H. Sandstead, D.B. Milne, D.G. Heck and L.M. Klevay, Nutrition status and brain function in aging, Am. J. Clin. Nutr. 52 (1990), 93-102.
285. C.L. Tully, D.A. Snowdon and W.R. Markesbery, Serum zinc, senile plaques, and neurofibrillary tangles: findings from the Nun Study, Neuroreport 13 (1995), 2105-2108.
286. A.G. van Rhijn, A.C. Prior and F.M. Corrigan, Dietary Supplementation with Zinc Sulphate, Sodium Selenite and Fatty Acids in early dementia of Alzheimer's type, J. Nutr. Med. 1 (1990), 259-266.
287. M. Vanhanen, J. Kuusisto, K. Koivisto, L. Mykkanen, E.L. Helkala, T. Hanninen, P. Sr. Riekkinen, H. Soininen and M. Laakso, Type-2 diabetes and cognitive function in a nondemented population, Acta Neurol. Scand. 100 (1999), 97-101.
288. S.E. Vermeer, E.J. van Dijk, P.J. Koudstaal, M. Oudkerk, A. Hofman, R. Clarke and M.M. Breteler, Homocysteine, silent brain infarcts, and white matter lesions: The Rotterdam Scan Study, Ann. Neurol. 51 (2002), 285-289.
289. T. Vogt, Water Quality and Health: Study of a Possible Relation Between Aluminium in Drinking Water and Dementia, Sosiale og Økonomiske Studier no. 61, Oslo, Norway, 1986.
290. X. Zhu, H.G. Lee, G. Casadesus, J. Avila, K. Drew, G. Perry and M.A. Smith, Oxidative imbalance in Alzheimer's disease, Mol. Neurobiol. 31 (2005), 205-218.
291. H. Wang, G. Cao and R. Prior, Total antioxidant capacity of fruits, J. Agric. Food Chem. 44 (1996), 701-705.
292. G.I. Wenk and K.L. Stemmer, Suboptimal dietary zinc increases aluminium accumulation in the rat brain, Brain Res. 288 (1983), 393-395.
293. G.L. Wenk, An hypothesis on the role of glucose in the mechanism of action of cognitive enhancers, Psychopharmacology 99 (1989), 431-438.
294. A. Wettstein, J. Aeppli, K. Gautschi and M. Peters, Failure to find a relationship between mnestic skills of octogenarians and aluminum in drinking water, Int. Arch. Occup. Environ. Health. 63 (1991), 97-103.
295. L. White, H. Petrovitch, G.W. Ross, K.H. Masaki, R.D. Abbott, E.L. Teng, B.L. Rodriguez, P.L. Blanchette, R.J. Havlik, G. Wergowske, D. Chiu, D.J. Foley, C. Murdaugh and J.D. Curb, Prevalence of dementia in older Japanese-American men in Hawaii, J.A.M.A. 276 (1996), 955-960.
296. P.J. Whitehouse, C.G. Sciulli and R.M. Mason, Dementia drug development: use of information systems to harmonize global drug development, Psychopharmacol. Bull. 33 (1997), 129-133.
297. G. Winocur and C.E. Greenwood, The effects of high fat diets and environmental influences on cognitive performance in rats, Behav. Brain Res. 101 (1999), 153-161.
298. R.J. Wurtman, Effects of their nutrient precursors on the synthesis and release of serotonin, the catecholamines, and acetylcholine: implications for behavioral disorders, Clin. Neuropharmacol. 11(Suppl 1) (1988), S187.
299. Y. Yoshiike, K. Tanemura, O. Murayama, T. Akagi, M. Murayama, S. Sato, X. Sun, N. Tanaka and A. Takashima, New insights on how metals disrupt amyloid beta-aggregation and their effects on amyloid-beta cytotoxicity, J. Biol. Chem. 276 (2001), 32293-32299.